What is the appropriate medical management for a patient with diabetic ketoacidosis?

Medical Management of Diabetic Ketoacidosis

Initial Resuscitation and Assessment

Begin aggressive isotonic saline (0.9% NaCl) at 15–20 mL/kg/hour (approximately 1–1.5 L in the first hour) immediately to restore intravascular volume and renal perfusion. 1

Diagnostic Workup

• Obtain plasma glucose, arterial or venous pH, serum electrolytes with calculated anion gap, β-hydroxybutyrate (preferred ketone test), BUN, creatinine, effective serum osmolality (2 × [Na] + glucose/18), urinalysis with ketones, complete blood count with differential, and ECG 1
• Collect blood, urine, and throat cultures if infection is suspected, as infection is the most common precipitating factor 1
• DKA diagnostic criteria: glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <15 mEq/L, moderate-to-large ketonuria/ketonemia, and anion gap >12 mEq/L 1
• Note that euglycemic DKA (glucose <200–250 mg/dL with acidosis and ketosis) is increasingly recognized, particularly with SGLT2 inhibitor use 1

---

Fluid Management After First Hour

• Calculate corrected serum sodium by adding 1.6 mEq/L for each 100 mg/dL glucose above 100 mg/dL 1
• If corrected sodium is normal or elevated: switch to 0.45% NaCl at 4–14 mL/kg/hour 1
• If corrected sodium is low: continue 0.9% NaCl at 4–14 mL/kg/hour 1
• When glucose falls to 250 mg/dL: change IV fluids to 5% dextrose with 0.45–0.75% NaCl while maintaining insulin infusion to prevent hypoglycemia and ensure complete ketoacidosis resolution 1
• Aim to replace the total fluid deficit (typically 6–9 L) within 24 hours while limiting the change in serum osmolality to ≤3 mOsm/kg/hour to reduce cerebral edema risk 1

---

Critical Potassium Management

Total body potassium depletion is universal in DKA (approximately 3–5 mEq/kg) even if serum potassium appears normal or elevated initially. 1

Potassium Replacement Protocol

• If K⁺ <3.3 mEq/L: HOLD INSULIN and replace potassium aggressively at 20–40 mEq/hour until K⁺ ≥3.3 mEq/L to prevent life-threatening arrhythmias, cardiac arrest, and respiratory muscle weakness 1
• If K⁺ = 3.3–5.5 mEq/L: add 20–30 mEq potassium per liter of IV fluid (approximately 2/3 KCl + 1/3 KPO₄) once adequate urine output is confirmed 1
• If K⁺ >5.5 mEq/L: withhold potassium initially but monitor every 2–4 hours, as levels will fall rapidly with insulin therapy 1
• Target serum potassium throughout treatment: 4–5 mEq/L 1

Common Pitfall

Starting insulin before correcting severe hypokalemia (K⁺ <3.3 mEq/L) is a leading cause of mortality in DKA because insulin drives potassium intracellularly, precipitating fatal arrhythmias 1

---

Insulin Therapy

Verify serum potassium ≥3.3 mEq/L before initiating insulin. 1

Standard IV Protocol (Moderate-to-Severe or Critically Ill DKA)

• Give an optional IV bolus of regular insulin 0.1–0.15 units/kg 1
• Start continuous IV regular insulin infusion at 0.1 units/kg/hour 1
• Target glucose decline: 50–75 mg/dL per hour 1
• If glucose does not decrease by ≥50 mg/dL in the first hour despite adequate hydration, double the insulin infusion rate each subsequent hour until a steady decline is achieved 1

Alternative for Mild-to-Moderate Uncomplicated DKA

• For hemodynamically stable, alert patients with mild-to-moderate DKA, subcutaneous rapid-acting insulin analogs at 0.15 units/kg every 2–3 hours combined with aggressive fluid management are equally effective, safer, and more cost-effective than IV insulin 1
• This approach requires adequate fluid replacement, frequent point-of-care glucose monitoring, and treatment of concurrent infections 1
• Continuous IV insulin remains the standard of care for critically ill and mentally obtunded patients 1

Critical Insulin Management Points

• When glucose reaches 250 mg/dL, add dextrose to IV fluids while continuing insulin infusion 1
• Continue insulin infusion until DKA resolution (pH >7.3, bicarbonate ≥18 mEq/L, anion gap ≤12 mEq/L) regardless of glucose level 1
• Stopping insulin when glucose falls to 250 mg/dL without adding dextrose is a common cause of recurrent ketoacidosis 1

---

Monitoring During Treatment

• Draw blood every 2–4 hours for serum electrolytes, glucose, BUN, creatinine, calculated osmolality, and venous pH 1
• Use venous pH (approximately 0.03 units lower than arterial) for ongoing assessment; repeat arterial blood gases are generally unnecessary 1
• Measure β-hydroxybutyrate in blood as the preferred method for monitoring ketosis resolution 1
• Avoid nitroprusside-based ketone tests (urine or blood), which detect only acetoacetate and acetone, missing the predominant ketone body (β-hydroxybutyrate) and may delay appropriate therapy 1

---

Bicarbonate Administration

Do NOT administer bicarbonate for DKA patients with pH >6.9–7.0. 1

Multiple studies show no difference in resolution of acidosis or time to discharge with bicarbonate use, and it may worsen ketosis, cause hypokalemia, and increase cerebral edema risk 1

---

Identification and Treatment of Precipitating Causes

• Actively search for and treat common precipitants: infection (most common), myocardial infarction, stroke, insulin omission or inadequacy, pancreatitis, SGLT2 inhibitor use, glucocorticoid therapy, and pregnancy 1
• Obtain bacterial cultures and start appropriate antibiotics when infection is suspected 1
• SGLT2 inhibitors must be discontinued immediately and not restarted until 3–4 days after metabolic stability is achieved 1

---

Transition to Subcutaneous Insulin

Administer basal subcutaneous insulin (intermediate or long-acting such as glargine, detemir, or NPH) 2–4 hours BEFORE stopping the IV insulin infusion to prevent rebound hyperglycemia and recurrence of ketoacidosis. 1

• Once the patient can tolerate oral intake, initiate a multiple-dose insulin regimen using short/rapid-acting plus intermediate/long-acting insulin 1
• For newly diagnosed patients, start total daily insulin dose of approximately 0.5–1.0 units/kg/day 1
• Recent evidence suggests that adding a low-dose basal insulin analog during the IV insulin infusion may prevent rebound hyperglycemia without increasing hypoglycemia risk 1

---

Common Pitfalls to Avoid

• Inadequate potassium monitoring and replacement is a leading cause of mortality in DKA 1
• Premature termination of insulin therapy before complete resolution of ketosis leads to recurrent DKA 1
• Overly rapid correction of serum osmolality (>3 mOsm/kg/hour) increases the risk of cerebral edema, particularly in children 1
• Reliance on nitroprusside-based ketone tests misses β-hydroxybutyrate and delays appropriate treatment 1
• Stopping IV insulin without prior administration of basal subcutaneous insulin causes rebound hyperglycemia and ketoacidosis 1

---

Discharge Planning

• Verify that the patient has identified an outpatient diabetes care provider before discharge 1
• Educate patients on recognition, prevention, and management of DKA to prevent recurrence and readmission 1
• Ensure appropriate insulin regimen is prescribed with attention to medication access and affordability 1
• Schedule follow-up appointments prior to discharge 1